Cargando…

Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.

Detalles Bibliográficos
Autores principales: Newman, C. E., Cox, R., Ford, C. H., Johnson, J. R., Jones, D. R., Wheaton, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1985
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977056/
https://www.ncbi.nlm.nih.gov/pubmed/3888243
_version_ 1782135181122994176
author Newman, C. E.
Cox, R.
Ford, C. H.
Johnson, J. R.
Jones, D. R.
Wheaton, M.
author_facet Newman, C. E.
Cox, R.
Ford, C. H.
Johnson, J. R.
Jones, D. R.
Wheaton, M.
author_sort Newman, C. E.
collection PubMed
description
format Text
id pubmed-1977056
institution National Center for Biotechnology Information
language English
publishDate 1985
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19770562009-09-10 Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial. Newman, C. E. Cox, R. Ford, C. H. Johnson, J. R. Jones, D. R. Wheaton, M. Br J Cancer Research Article Nature Publishing Group 1985-05 /pmc/articles/PMC1977056/ /pubmed/3888243 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Newman, C. E.
Cox, R.
Ford, C. H.
Johnson, J. R.
Jones, D. R.
Wheaton, M.
Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.
title Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.
title_full Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.
title_fullStr Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.
title_full_unstemmed Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.
title_short Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.
title_sort reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977056/
https://www.ncbi.nlm.nih.gov/pubmed/3888243
work_keys_str_mv AT newmance reducedsurvivalwithradiotherapyandrazoxanecomparedwithradiotherapyaloneforinoperablelungcancerinarandomiseddoubleblindtrial
AT coxr reducedsurvivalwithradiotherapyandrazoxanecomparedwithradiotherapyaloneforinoperablelungcancerinarandomiseddoubleblindtrial
AT fordch reducedsurvivalwithradiotherapyandrazoxanecomparedwithradiotherapyaloneforinoperablelungcancerinarandomiseddoubleblindtrial
AT johnsonjr reducedsurvivalwithradiotherapyandrazoxanecomparedwithradiotherapyaloneforinoperablelungcancerinarandomiseddoubleblindtrial
AT jonesdr reducedsurvivalwithradiotherapyandrazoxanecomparedwithradiotherapyaloneforinoperablelungcancerinarandomiseddoubleblindtrial
AT wheatonm reducedsurvivalwithradiotherapyandrazoxanecomparedwithradiotherapyaloneforinoperablelungcancerinarandomiseddoubleblindtrial